Magnetic Agarose Microspheres/Hyaluronic Acid Hydrogel as a Trackable Bulking Agent for Vesicoureteral Reflux Treatment
Vesicoureteral reflux (VUR) is one of the most common congenital anomalies in the kidney and the urinary tract. Endoscopic subureteral injection of a bulking agent has become popular in VUR treatment due to its high success rates, few complications, and a straightforward procedure. In this study, a...
Main Authors: | Hong Chen, Pan Wu, Hong Xu, Changchun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2021.746609/full |
Similar Items
-
Treatment Outcomes of Subureteric Injection and Ureteroneocystostomy in Children with Vesicoureteral Reflux
by: Serkan Arslan, et al.
Published: (2016-06-01) -
Endoscopic Management of Complicated Highgrade Vesicoureteral Reflux in the First Year of Life
by: Ali Tekin, et al.
Published: (2021-09-01) -
SUBURETERAL MUCOSA INJECTION WITH DETRANOMER/HYALURONIC ACID FOR VESICOURETERAL REFLUX TREATMENT: SYSTEMATIC REVIEW
by: Nicholas Tambunan, et al.
Published: (2017-03-01) -
Endoscopic Treatment of Vesicoureteral Reflux: Changing Trends Over the Years
by: Taner Ceylan, et al.
Published: (2021-06-01) -
Advantages and disadvantages of various bulking agents in endoscopic treatment of vesicoureteral reflux
by: Juloski Jovan T., et al.
Published: (2014-01-01)